FDA
There are two general causes of oxygen regulator fires, adiabatic heating and particle ignition
The Drug Supply Chain Security Act mandates pharmaceutical tracking, tracing and documentation for EMS agencies
The move sets off what will be the largest vaccination campaign in U.S. history
The FDA could sign off on emergency use of the vaccine within days following the advisory panel’s recommendation
The at-home test that yields results in under an hour was trialed by firefighters who called it “a great resource”
The company says its vaccine is more than 94% effective and presents “no serious safety concerns”
The company has asked the FDA for approval to begin distributing its vaccines as early as next month
James Poole, 37, a former Mercy Medical Center paramedic, was accused of stealing from dozens of medication vials and replacing their contents
The tests can be self-administered at home and sent to a lab for processing
By leveraging naloxone and buprenorphine, along with behavioral therapies, medication-assisted treatment attacks opioid addiction from all sides
The approval is part of the FDA’s push to make the drug more readily available
Researchers found that the FDA and opioid manufacturers failed to monitor the restricted use of a powerful type of fentanyl even after problems were discovered
Dsuvia, a new medication five to 10 times more powerful than fentanyl, was approved to be prescribed to patients in hospital settings
FDA Commissioner Scott Gottlieb said the approval is part of a “longstanding commitment to advance access to lower cost, safe and effective alternatives”
The monthly injection has the potential to reduce dangerous relapses that occur when patients stop taking the currently available daily medication
The nerve stimulator is the first device to treat such symptoms including joint pain, anxiety, stomach aches and insomnia
The agency notified 74 manufacturers of so-called immediate-release opioids that their drugs will now be subject to the tougher requirements
It’s possible to stem the crisis without denying opioids to patients whose doctors prescribe them responsibly
It’s the first time the FDA has asked a drugmaker to remove an opioid painkiller from the market
The letter reiterated support for a thorough, nationwide approach to resolving the systematic issue of opioid abuse
Participants in the studies reported MDMA therapy “not only helped them with painful memories, but also had helped them stop abusing alcohol and other drugs”
The contest is aimed at developing a mobile phone app that will help a person having or witnessing an opioid overdose get the quickest access to naloxone
The proposed rule will be available for public comment for 180 days
The six-month buprenorphine implant provides a new maintenance treatment option for those in recovery
Under the current risk programs, drugmakers fund voluntary training for physicians in safely prescribing their medications
The new labels are part of an attempt to stem the rise of addiction and overdose deaths tied to opioid painkillers
The drug will target tumor cells while allowing healthy ones to survive